Ever-evolving landscape of biosimilars in Canada; findings and implications from a global perspective

Godman, Brian and Allocati, Eleonora and Moorkens, Evelien (2019) Ever-evolving landscape of biosimilars in Canada; findings and implications from a global perspective. Generics and Biosimilars Initiative journal. ISSN 2033-6403 (In Press)

[img]
Preview
 Text (Godman-etal-GBIJ-2019-Ever-evolving-landscape-of-biosimilars-in-Canada)
Godman_etal_GBIJ_2019_Ever_evolving_landscape_of_biosimilars_in_Canada.pdf
Accepted Author Manuscript
Download (398kB)| Preview

    Abstract

    Siu et al. have comprehensively assessed the rapidly changing regulation and reimbursement environment for biologicals and biosimilars in Canada and the resultant implications.

    Author(s):Godman, Brian, Allocati, Eleonora and Moorkens, Evelien
    Item type:Article
    ID code:69797
    Keywords:biosimilars, Canada, reimbursement, health policies, Pharmacy and materia medica, Pharmacology, Toxicology and Pharmaceutics(all)
    Subjects:Medicine > Pharmacy and materia medica
    Department:Faculty of Science > Strathclyde Institute of Pharmacy and Biomedical Sciences
    Depositing user: Pure Administrator
    Date deposited:13 Sep 2019 09:23
    Last modified:21 Nov 2019 03:17
    URI:https://strathprints.strath.ac.uk/id/eprint/69797
    Export data:
    CORE (COnnecting REpositories)